AZD-5991 Uses, Dosage, Side Effects and more
AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).
| Attribute | Details |
|---|---|
| Trade Name | AZD-5991 |
| Generic | AZD-5991 |
| Type | |
| Formula | C35H34ClN5O3S2 |
| Weight | Average: 672.26 Monoisotopic: 671.17916 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
